|
1
|
Guo Z, Xiao D, Wang X, Wang Y and Yan T:
Epidemiological characteristics of pulmonary tuberculosis in
mainland China from 2004 to 2015: A model-based analysis. BMC
Public Health. 19(219)2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Xu Y, Wu J, Liao S and Sun Z: Treating
tuberculosis with high doses of anti-TB drugs: Mechanisms and
outcomes. Ann Clin Microbiol Antimicrob. 16(67)2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Carvalho AC, Cardoso CA, Martire TM,
Migliori GB and Sant'Anna CC: Epidemiological aspects, clinical
manifestations, and prevention of pediatric tuberculosis from the
perspective of the end TB strategy. J Bras Pneumol. 44:134–144.
2018.PubMed/NCBI View Article : Google Scholar : (In Portuguese,
English).
|
|
4
|
Rao VG, Bhat J, Yadav R, Muniyandi M,
Bhondeley MK and Wares DF: Yield of pulmonary tuberculosis cases by
symptoms: Findings from a community survey in Madhya Pradesh,
central India. Indian J Tuberc. 62:121–123. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Shen X, Zhang J, Tang P, Song H, Liu X,
Huang Z, Zhang X, Wang X and Wu M: Expression and clinical
significance of B and T lymphocyte attenuator on CD4+
and CD8+ T cells from patients with pulmonary
tuberculosis. Indian J Pathol Microbiol. 62:232–238.
2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Peng X, Luo T, Zhai X, Zhang C, Suo J, Ma
P, Wang C and Bao L: PPE11 of Mycobacterium tuberculosis can alter
host inflammatory response and trigger cell death. Microb Pathog.
126:45–55. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Rekha RS, Mily A, Sultana T, Haq A, Ahmed
S, Mostafa Kamal SM, van Schadewijk A, Hiemstra PS, Gudmundsson GH,
Agerberth B and Raqib R: Immune responses in the treatment of
drug-sensitive pulmonary tuberculosis with phenylbutyrate and
vitamin D3 as host directed therapy. BMC Infect Dis.
18(303)2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Tomio J, Yamana H, Matsui H, Yamashita H,
Yoshiyama T and Yasunaga H: Tuberculosis screening prior to
anti-tumor necrosis factor therapy among patients with
immune-mediated inflammatory diseases in Japan: A longitudinal
study using a large-scale health insurance claims database. Int J
Rheum Dis. 20:1674–1683. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Tornheim JA and Dooley KE: The global
landscape of tuberculosis therapeutics. Annu Rev Med. 70:105–120.
2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Khameneh B, Fazly Bazzaz BS, Amani A,
Rostami J and Vahdati-Mashhadian N: Combination of
anti-tuberculosis drugs with vitamin C or NAC against different
Staphylococcus aureus and Mycobacterium tuberculosis strains.
Microb Pathog. 93:83–87. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zittermann A: Vitamin D in preventive
medicine: Are we ignoring the evidence? Br J Nutr. 89:552–572.
2003.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Syal K, Chakraborty S, Bhattacharyya R and
Banerjee D: Combined inhalation and oral supplementation of Vitamin
A and Vitamin D: A possible prevention and therapy for
tuberculosis. Med Hypotheses. 84:199–203. 2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Huang SJ, Wang XH, Liu ZD, Cao WL, Han Y,
Ma AG and Xu SF: Vitamin D deficiency and the risk of tuberculosis:
A meta-analysis. Drug Des Devel Ther. 11:91–102. 2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Li CT, Chu KH, Reiher B, Kienene T and
Chien LY: Evaluation of health-related quality of life in patients
with tuberculosis who completed treatment in Kiribati. J Int Med
Res. 45:610–620. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ossalé Abacka KB, Koné A, Akoli Ekoya O,
Bopaka RG, Lankoandé Siri H and Horo K: Extrapulmonary tuberculosis
versus pulmonary tuberculosis: Epidemiological, diagnosis and
evolutive aspects. Rev Pneumol Clin. 74:452–457. 2018.PubMed/NCBI View Article : Google Scholar : (In French).
|
|
16
|
Maitra A, Kamil TK, Shaik M, Danquah CA,
Chrzastek A and Bhakta S: Early diagnosis and effective treatment
regimens are the keys to tackle antimicrobial resistance in
tuberculosis (TB): A report from Euroscicon's international TB
Summit 2016. Virulence. 8:1005–1024. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Churchyard G, Kim P, Shah NS, Rustomjee R,
Gandhi N, Mathema B, Dowdy D, Kasmar A and Cardenas V: What we know
about tuberculosis transmission: An overview. J Infect Dis. 216
(suppl 6):S629–S635. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Reynolds IR and Chan ED: An update on the
trends and treatment in multidrug-resistant tuberculosis. Am J
Respir Crit Care Med. 193:A5533. 2016.
|
|
19
|
An J, Bai X, Gao M, Chu N, Huang H, Xu H,
Zhang X, Li B, Huang C, Cai H, et al: Antituberculosis drug
prescribing for inpatients in a national tuberculosis hospital in
China, 2011-2015. J Glob Antimicrob Resist. 14:17–22.
2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Gegia M, Winters N, Benedetti A, van
Soolingen D and Menzies D: Treatment of isoniazid-resistant
tuberculosis with first-line drugs: A systematic review and
meta-analysis. Lancet Infect Dis. 17:223–234. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Hu Y, Wu X, Luo J, Fu Y, Zhao L, Ma Y, Li
Y, Liang Q, Shang Y and Huang H: Detection of pyrazinamide
resistance of Mycobacterium tuberculosis using nicotinamide as a
surrogate. Clin Microbiol Infect. 23:835–838. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Alessandra C Pinheiro and Marcus V N de
Souza. The relevance of new drug combinations for modern
tuberculosis treatment-a patent perspective. Recent Pat Antiinfect
Drug Discov. 8:130–138. 2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Li C, Liu L and Tao Y: Diagnosis and
treatment of congenital tuberculosis: A systematic review of 92
cases. Orphanet J Rare Dis. 14(131)2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Lewinsohn DM, Leonard MK, LoBue PA, Cohn
DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM,
Mazurek GH, et al: Official American Thoracic Society/Infectious
Diseases Society of America/Centers for disease control and
prevention clinical practice guidelines: Diagnosis of tuberculosis
in adults and children. Clin Infect Dis. 64:–e1. –e33.
2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Haris R, Irbaz R, Tanvir A, Maaz B and
Abul M: Vitamin D as a supplementary agent in the treatment of
pulmonary tuberculosis: A systematic review and meta-analysis of
randomized controlled trials. Eur Respir J. 42(4623)2013.
|
|
26
|
Li C, Zhou HC, Nie YL, Zhao BY and Wu CC:
Effects of lipopolysaccharide on T lymphocyte cell subsets and
cytokine secretion in mesenteric lymph nodes of mice: Histological
and molecular study. Environ Toxicol Pharmacol.
71(103214)2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Pérez-Antón E, Egui A, Thomas MC, Puerta
CJ, González JM, Cuéllar A, Segovia M and López MC: Impact of
benznidazole treatment on the functional response of Trypanosoma
cruzi antigen-specific CD4+CD8+ T cells in
chronic Chagas disease patients. PLoS Negl Trop Dis.
12(e0006480)2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Muller L, Mitsuhashi M, Simms P, Gooding
WE and Whiteside TL: Tumor-derived exosomes regulate expression of
immune function-related genes in human T cell subsets. Sci Rep.
6(20254)2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Jiménez-Sousa MÁ, Martínez I, Medrano LM,
Fernández-Rodríguez A and Resino S: Vitamin D in human
immunodeficiency virus infection: Influence on immunity and
disease. Front Immunol. 9(458)2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Naik SP, Mahesh PA, Jayaraj BS,
Madhunapantula SV, Jahromi SR and Yadav MK: Evaluation of
inflammatory markers interleukin-6 (IL-6) and matrix
metalloproteinase-9 (MMP-9) in asthma. J Asthma. 54:584–593.
2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Acharya AB, Thakur S, Muddapur MV and
Kulkarni RD: Tumor necrosis factor-α, interleukin-4 and -6 in the
serum of health, chronic periodontitis, and type 2 diabetes
mellitus. J Indian Soc Periodontol. 20:509–513. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Selvaraj P, Harishankar M and Afsal K:
Vitamin D: Immuno-modulation and tuberculosis treatment. Can J
Physiol Pharmacol. 93:377–384. 2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Güzel A, Karadağ A, Okuyucu A, Alaçam H
and Küçük Y: The evaluation of serum surfactant protein D (SP-D)
levels as a biomarker of lung injury in tuberculosis and different
lung diseases. Clin Lab. 60:1091–1098. 2014.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Enomoto Y, Hagiwara E, Komatsu S,
Nishihira R, Baba T and Ogura T: Comparison of biomarkers of
pulmonary tuberculosis activity-serum surfactant proteins A and D,
KL-6, C-reactive protein, and erythrocyte sedimentation rate.
Kekkaku. 89:637–642. 2014.PubMed/NCBI(In Japanese).
|
|
35
|
Serré J, Mathyssen C, Ajime TT, Korf H,
Maes K, Heulens N, Gysemans C, Mathieu C, Vanaudenaerde B, Janssens
W and Gayan-Ramirez G: Data on inflammatory cytokines and pathways
involved in clearance of nontypeable Haemophilus influenzae
from the lungs during cigarette smoking and vitamin D deficiency.
Data Brief. 22:703–708. 2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Mukae H, Ashitani J, Tokojima M, Ihi T,
Kohno S and Matsukura S: Elevated levels of circulating adhesion
molecules in patients with active pulmonary tuberculosis.
Respirology. 8:326–331. 2003.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Nowak JK, Wojsyk-Banaszak I, Mądry E,
Wykrętowicz A, Krzyżanowska P, Drzymała-Czyż S, Nowicka A,
Pogorzelski A, Sapiejka E, Skorupa W, et al: Increased soluble
VCAM-1 and normal P-selectin in cystic fibrosis: A cross-sectional
study. Lung. 195:445–453. 2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Xia J, Shi L, Zhao L and Xu F: Impact of
vitamin D supplementation on the outcome of tuberculosis treatment:
A systematic review and meta-analysis of randomized controlled
trials. Chin Med J (Engl). 127:3127–3134. 2014.PubMed/NCBI
|
|
39
|
Bai YJ and Dai RJ: Serum levels of vitamin
A and 25-hydroxyvitamin D3 (25OHD3) as reflectors of
pulmonary function and quality of life (QOL) in children with
sTable asthma: A case-control study. Medicine (Baltimore).
97(e9830)2018.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Alavi Foumani A, Mehrdad M, Jafarinezhad
A, Nokani K and Jafari A: Impact of vitamin D on spirometry
findings and quality of life in patients with chronic obstructive
pulmonary disease: A randomized, double-blinded, placebo-controlled
clinical trial. Int J Chron Obstruct Pulmon Dis. 14:1495–1501.
2019.PubMed/NCBI View Article : Google Scholar
|
